How Does Boston Scientific Make its Money?
Boston Scientific is a global medical technology company that develops and markets devices used in interventional medical specialties. The company’s products span cardiovascular, rhythm management, endoscopy, urology, and neuromodulation. Boston Scientific has transformed itself over the past decade from a struggling device maker into one of the fastest-growing medtech companies, fueled by innovation in electrophysiology (FARAPULSE pulsed field ablation system), structural heart, and single-use endoscopy.
Boston Scientific (BSX) Business Model
Boston Scientific operates in the medical devices sector. Below is a summary of Boston Scientific’s revenue streams, how the company generates income, and the key financial metrics from its most recent annual report. This breakdown uses data from Boston Scientific’s 2024 fiscal year filings with the SEC.
Boston Scientific Competitors
Boston Scientific’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Abbott Laboratories, and Johnson & Johnson. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Boston Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Boston Scientific Competitors
Boston Scientific’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Abbott Laboratories, and Johnson & Johnson. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Boston Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Boston Scientific Competitors
Boston Scientific’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Abbott Laboratories, and Johnson & Johnson. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Boston Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Boston Scientific Competitors
Boston Scientific’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Abbott Laboratories, and Johnson & Johnson. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Boston Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Boston Scientific Competitors
Boston Scientific’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Abbott Laboratories, and Johnson & Johnson. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Boston Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Boston Scientific Competitors
Boston Scientific’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Abbott Laboratories, and Johnson & Johnson. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Boston Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Revenue Breakdown
| Segment | 2024 | 2023 | YoY Growth |
|---|---|---|---|
| MedSurg (Endoscopy, Urology) | $5,400 | $4,800 | +12.5% |
| Cardiovascular | $10,500 | $8,900 | +18.0% |
| Total Revenue | $16,700 | $14,200 | +17.6% |
MedSurg (Endoscopy, Urology) — 32% of Revenue
Cardiovascular — 63% of Revenue
Income Statement Overview
| Metric | 2024 | 2023 |
|---|---|---|
| Total Revenue | $16,700 | $14,200 |
| Cost of Revenue | $5,100 | $4,500 |
| Gross Profit | $11,600 | $9,700 |
| Operating Expenses | $7,200 | $6,300 |
| Operating Income | $4,400 | $3,400 |
| Net Income | $2,700 | $1,700 |
All values in millions USD unless otherwise stated.
Key Financial Metrics
- Gross Margin: 69.5%
- Operating Margin: 26.3%
- Revenue Growth: 17.6%
Is Boston Scientific Profitable?
Yes, Boston Scientific is profitable. The company reported net income of $2,700 on total revenue of $16,700. With an operating margin of 26.3%, Boston Scientific demonstrates solid profitability for the medical devices sector. The gross margin of 69.5% reflects Boston Scientific’s pricing power and cost structure.
What to Watch
- FARAPULSE pulsed field ablation system adoption and electrophysiology market share gains
- WATCHMAN left atrial appendage closure device growth trajectory
- Integration of recent acquisitions and pipeline expansion
- Competition from Medtronic and Abbott in key cardiovascular categories
Boston Scientific (BSX) Financial Summary
Boston Scientific (BSX) is a medical devices company that generated $16,700 in total revenue in fiscal year 2024. Revenue grew 17.6% year-over-year. The company earned $2,700 in net income, making it profitable. For a deeper look at Boston Scientific’s revenue breakdown, business segments, and financial performance, review the detailed analysis above.